Claire Perrin Smith
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Claire Perrin Smith has a total of 296 co-authors. Here are the top co-authors by number of shared publications:
- Justin Lessler
University of North Carolina at Chapel Hill
11 shared publications - Shaun Truelove
Johns Hopkins University
10 shared publications - Cécile Viboud
Fogarty International Center, National Institutes of Health, Bethesda, MD, USA
9 shared publications - Emily Howerton
Department of Ecology and Evolutionary Biology, Princeton University, Princeton, USA
9 shared publications - Alessandro Vespignani
Network Science Institute, Northeastern University, Boston, MA, USA
8 shared publications - Bryan Lewis
University of Virginia, Charlottesville, VA, USA
8 shared publications
Latest Publications
- Open Access
- 11 November 2026
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
Multi-model insights into racial and ethnic heterogeneities in early COVID-19 transmission and severity in the U.S.
The COVID-19 pandemic was marked by unequal disease burden across racial and ethnic groups in the US. Using a multi-model ensemble framework, we retrospectively assessed the impact of racial and ethnic heterogeneities in COVID-19 transmission and disease severity on mortality during the winter 2020–2021 surge in California and North Carolina. Models incorporating race and ethnicity projected mortality more accurately than null models, while the ensemble outperformed all individual models on average by weighted interval scores. Eliminating transmission heterogeneities produced larger mortality reductions than eliminating severity differences alone, particularly for Latino populations in California (55% reduction) and Black populations in North Carolina (28% reduction). Reducing severity heterogeneity also lowered mortality, with the greatest benefit among Black populations in both states (21% and 16% reductions in California and North Carolina, respectively). Eliminating both transmission and severity heterogeneity yielded the largest reductions overall, predicting 49–70% lower mortality across racial and ethnic groups in California and 23–40% in North Carolina. Mitigating transmission inequities also produced indirect benefits for non-targeted populations, highlighting the broad impact of reducing disparities in exposure risk and access to protective resources.
- 11 November 2026
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
Open AccessMulti-model insights into racial and ethnic heterogeneities in early COVID-19 transmission and severity in the U.S.
The COVID-19 pandemic was marked by unequal disease burden across racial and ethnic groups in the US. Using a multi-model ensemble framework, we retrospectively assessed the impact of racial and ethnic heterogeneities in COVID-19 transmission and disease severity on mortality during the winter 2020–2021 surge in California and North Carolina. Models incorporating race and ethnicity projected mortality more accurately than null models, while the ensemble outperformed all individual models on average by weighted interval scores. Eliminating transmission heterogeneities produced larger mortality reductions than eliminating severity differences alone, particularly for Latino populations in California (55% reduction) and Black populations in North Carolina (28% reduction). Reducing severity heterogeneity also lowered mortality, with the greatest benefit among Black populations in both states (21% and 16% reductions in California and North Carolina, respectively). Eliminating both transmission and severity heterogeneity yielded the largest reductions overall, predicting 49–70% lower mortality across racial and ethnic groups in California and 23–40% in North Carolina. Mitigating transmission inequities also produced indirect benefits for non-targeted populations, highlighting the broad impact of reducing disparities in exposure risk and access to protective resources.
- 20 October 2026
- Published by The R Foundation
hestia: Bayesian Compartmental Infection Models from Individual Outcomes
Fit Bayesian compartmental infection models (such as susceptible-infected-recovered and multi-compartment hidden Markov variants) from individual-level outcome data. Models are composed from infection-process and observation-process components and fit using Stan via 'rstan'.
- 20 October 2026
- Published by The R Foundation
hestia: Bayesian Compartmental Infection Models from Individual Outcomes
Fit Bayesian compartmental infection models (such as susceptible-infected-recovered and multi-compartment hidden Markov variants) from individual-level outcome data. Models are composed from infection-process and observation-process components and fit using Stan via 'rstan'.
- Open Access
Adaptive multi-model ensembles for improved epidemic projections and decision support
In recent years, the use of multi-model ensemble projections in infectious disease modeling has become an established methodological approach to account for and integrate across uncertainties and structural differences present in individual models. However, the creation of long-term ensemble projections through these coordinated efforts is resource-intensive, demanding the input of multiple research teams and substantial computational power. This typically limits the ability to refine projections, update the selection of plausible epidemic trajectories, or expand the number of scenarios that can be assessed, even as new empirical data become available. To address this challenge, we define an adaptive ensemble approach that, analogously to a multi-model particle filtering method, dynamically selects individual model trajectories based on observed data throughout the epidemic projection period. We demonstrate the effectiveness of this methodology using the U.S. Flu Scenario Modeling Hub (SMH) projections for influenza hospitalizations in the United States during the 2023-2024 and 2024-2025 winter seasons. Our findings show that the adaptive ensemble yields improved predictive accuracy with respect to the original SMH ensemble projections across several scoring rules and geographical resolutions. Furthermore, the adaptive ensemble approach offers two additional applications: i) the dynamic assignment of posterior probabilities to epidemic scenarios, identifying the most plausible scenario, and representing how reality is captured by a combination of scenarios, and ii) the potential use for short-term forecasting. The adaptive ensemble approach is able to identify the most likely scenarios for the 2023-2024 and 2024-2025 U.S. influenza seasons, even in the early stages of the epidemic. It outperforms, retrospectively, a baseline model in short-term forecasting of influenza hospitalizations in the United States during the two seasons across various horizons and scoring rules, showing potential to contribute to real-time collaborative forecasting challenges such as CDC’s FluSight. The proposed approach offers an efficient or low-resource strategy to increase the impact of multi-model epidemic projections by providing real-time support to modeling teams, public health authorities, and decision-makers.
Open AccessAdaptive multi-model ensembles for improved epidemic projections and decision support
In recent years, the use of multi-model ensemble projections in infectious disease modeling has become an established methodological approach to account for and integrate across uncertainties and structural differences present in individual models. However, the creation of long-term ensemble projections through these coordinated efforts is resource-intensive, demanding the input of multiple research teams and substantial computational power. This typically limits the ability to refine projections, update the selection of plausible epidemic trajectories, or expand the number of scenarios that can be assessed, even as new empirical data become available. To address this challenge, we define an adaptive ensemble approach that, analogously to a multi-model particle filtering method, dynamically selects individual model trajectories based on observed data throughout the epidemic projection period. We demonstrate the effectiveness of this methodology using the U.S. Flu Scenario Modeling Hub (SMH) projections for influenza hospitalizations in the United States during the 2023-2024 and 2024-2025 winter seasons. Our findings show that the adaptive ensemble yields improved predictive accuracy with respect to the original SMH ensemble projections across several scoring rules and geographical resolutions. Furthermore, the adaptive ensemble approach offers two additional applications: i) the dynamic assignment of posterior probabilities to epidemic scenarios, identifying the most plausible scenario, and representing how reality is captured by a combination of scenarios, and ii) the potential use for short-term forecasting. The adaptive ensemble approach is able to identify the most likely scenarios for the 2023-2024 and 2024-2025 U.S. influenza seasons, even in the early stages of the epidemic. It outperforms, retrospectively, a baseline model in short-term forecasting of influenza hospitalizations in the United States during the two seasons across various horizons and scoring rules, showing potential to contribute to real-time collaborative forecasting challenges such as CDC’s FluSight. The proposed approach offers an efficient or low-resource strategy to increase the impact of multi-model epidemic projections by providing real-time support to modeling teams, public health authorities, and decision-makers.
- 22 June 2026
- Published by The R Foundation
imuGAP: Immunity: Geographic and Age-Based Projection
- 4 June 2026
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 234 (1) , 30-39
Estimating the Transmission Potential of Symptomatic and Asymptomatic Cholera Cases From Household Microbiological and Clinical Data
Background: In Bangladesh, cholera treatment focuses on acute watery diarrhea in symptomatic cases at health facilities, though asymptomatic infections are common. Understanding the role of asymptomatic infections in transmission is crucial for designing appropriate control strategies in this setting. Methods: We utilized data from household studies conducted in Dhaka, Bangladesh, during 2006–2018 where a symptomatic confirmed cholera case and their household contacts were followed for 30 days. Vibriocidal antibodies, bacteriological culture, and symptom histories were collected at multiple time points. We used a hidden Markov model to estimate risk of infection from intra-household and extra-household (ie, community and environmental) sources and to quantify relative risk of transmission from symptomatic and asymptomatic infected household contacts. Results: Estimated daily risk of intra-household infection from a symptomatic individual to another household member was 2.6% (95% credible interval [CrI], .4%–5.6%) and from an asymptomatic infected individual to another household member was 1.6% (95% CrI, .2%–4.5%). We found no significant differences in probability of infection from asymptomatic compared to symptomatic individuals (odds ratio, 0.60 [95% CrI, .11–3.23]). We estimated that daily risk of infection from extra-household sources during follow-up was 1.0% (95% CrI, .7%–1.4%). Conclusions: Mitigation measures focused solely on treatment of symptomatic cholera cases may be insufficient to prevent transmission in a household. This supports use of interventions that reduce risk of transmission irrespective of symptoms, such as prophylactic antibiotic treatment for household members, vaccination, and/or providing safe water and hygiene kits following a confirmed household or community case.
- 4 June 2026
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 234 (1) , 30-39
Estimating the Transmission Potential of Symptomatic and Asymptomatic Cholera Cases From Household Microbiological and Clinical Data
Background: In Bangladesh, cholera treatment focuses on acute watery diarrhea in symptomatic cases at health facilities, though asymptomatic infections are common. Understanding the role of asymptomatic infections in transmission is crucial for designing appropriate control strategies in this setting. Methods: We utilized data from household studies conducted in Dhaka, Bangladesh, during 2006–2018 where a symptomatic confirmed cholera case and their household contacts were followed for 30 days. Vibriocidal antibodies, bacteriological culture, and symptom histories were collected at multiple time points. We used a hidden Markov model to estimate risk of infection from intra-household and extra-household (ie, community and environmental) sources and to quantify relative risk of transmission from symptomatic and asymptomatic infected household contacts. Results: Estimated daily risk of intra-household infection from a symptomatic individual to another household member was 2.6% (95% credible interval [CrI], .4%–5.6%) and from an asymptomatic infected individual to another household member was 1.6% (95% CrI, .2%–4.5%). We found no significant differences in probability of infection from asymptomatic compared to symptomatic individuals (odds ratio, 0.60 [95% CrI, .11–3.23]). We estimated that daily risk of infection from extra-household sources during follow-up was 1.0% (95% CrI, .7%–1.4%). Conclusions: Mitigation measures focused solely on treatment of symptomatic cholera cases may be insufficient to prevent transmission in a household. This supports use of interventions that reduce risk of transmission irrespective of symptoms, such as prophylactic antibiotic treatment for household members, vaccination, and/or providing safe water and hygiene kits following a confirmed household or community case.
- Open Access
Assessing the Impact of Timing and Coverage of United States COVID-19 Vaccination Campaigns: A Multi-Model Approach
Six years after its emergence, SARS-CoV-2 continues to have a substantial burden, however, the impact of vaccination and the optimal timing of its rollout remain uncertain. To explore these uncertainties, the US Scenario Modeling Hub convened its 19th round of ensemble projections for COVID-19 hospitalizations and deaths in the United States. Eight teams provided outcomes for each US state and nationally from April 2025 to April 2026 under five scenarios regarding vaccine recommendations and timing. We assessed recommendations with two eligibility scenarios (high-risk individuals only and all-eligible) and two timing scenarios (classic start: mid-August, earlier start: late June). These were crossed to create four scenarios and were compared against a counterfactual scenario with no vaccination. We found that compared to no vaccination, our ensemble projections estimated 90,000 (95% PI 53,000-126,000) hospitalizations averted in the high-risk and classic timing scenario across the US. Expanding coverage averted an additional 26,000 (95% PI 14,000-39,000) hospitalizations, which when coupled with earlier vaccination timing further reduced national hospitalizations by 15,000 (95% PI −3,000-33,000). These findings estimate significant benefits from a broad all-eligible vaccination recommendation, and suggest an additional benefit is likely to be gained from an earlier vaccination campaign.
Open AccessAssessing the Impact of Timing and Coverage of United States COVID-19 Vaccination Campaigns: A Multi-Model Approach
Six years after its emergence, SARS-CoV-2 continues to have a substantial burden, however, the impact of vaccination and the optimal timing of its rollout remain uncertain. To explore these uncertainties, the US Scenario Modeling Hub convened its 19th round of ensemble projections for COVID-19 hospitalizations and deaths in the United States. Eight teams provided outcomes for each US state and nationally from April 2025 to April 2026 under five scenarios regarding vaccine recommendations and timing. We assessed recommendations with two eligibility scenarios (high-risk individuals only and all-eligible) and two timing scenarios (classic start: mid-August, earlier start: late June). These were crossed to create four scenarios and were compared against a counterfactual scenario with no vaccination. We found that compared to no vaccination, our ensemble projections estimated 90,000 (95% PI 53,000-126,000) hospitalizations averted in the high-risk and classic timing scenario across the US. Expanding coverage averted an additional 26,000 (95% PI 14,000-39,000) hospitalizations, which when coupled with earlier vaccination timing further reduced national hospitalizations by 15,000 (95% PI −3,000-33,000). These findings estimate significant benefits from a broad all-eligible vaccination recommendation, and suggest an additional benefit is likely to be gained from an earlier vaccination campaign.
- Open Access
- 26 November 2025
- Published by The Royal Society in Journal of The Royal Society Interface
- Vol. 22 (232) , 20250232
First- and second-order social contact network structure in southern China
The contact network structure resulting from social interaction between people is a key aspect of epidemic dynamics and control. While many studies have measured first-order network characteristics such as degree, measuring higher order properties of these networks, such as clustering, remains a challenge. Here, we present the results of a study of first- and second-order network structure from a representative cohort of individuals in Guangdong province, China. The number of reported daily contacts is similar across individuals aged 2 to 55 years, except for young adults (ages 16–25) who have relatively fewer daily contacts, while the number of contacts declines with age above 55 years old. The association between age and contact rate persisted after adjusting for mediating factors. Individuals living in higher population density areas made more contacts outside the home than individuals in low-density areas. Contacts of young children and older adults were more locally clustered than middle-aged adults. Individuals living in high population density areas had lower levels of local clustering compared with individuals from low-density areas. Adjustment for characteristics of the contacts themselves reduces the variation in local clustering between participants of different ages; however, the strong association with population density remains.
- 26 November 2025
- Published by The Royal Society in Journal of The Royal Society Interface
- Vol. 22 (232) , 20250232
Open AccessFirst- and second-order social contact network structure in southern China
The contact network structure resulting from social interaction between people is a key aspect of epidemic dynamics and control. While many studies have measured first-order network characteristics such as degree, measuring higher order properties of these networks, such as clustering, remains a challenge. Here, we present the results of a study of first- and second-order network structure from a representative cohort of individuals in Guangdong province, China. The number of reported daily contacts is similar across individuals aged 2 to 55 years, except for young adults (ages 16–25) who have relatively fewer daily contacts, while the number of contacts declines with age above 55 years old. The association between age and contact rate persisted after adjusting for mediating factors. Individuals living in higher population density areas made more contacts outside the home than individuals in low-density areas. Contacts of young children and older adults were more locally clustered than middle-aged adults. Individuals living in high population density areas had lower levels of local clustering compared with individuals from low-density areas. Adjustment for characteristics of the contacts themselves reduces the variation in local clustering between participants of different ages; however, the strong association with population density remains.
- Open Access
The Trajectory of Antibody Responses One Year Following SARS-CoV-2 Infection among Indigenous Individuals in the Southwest United States
SARS-CoV-2 antibody kinetics based on immunologic history is not fully understood. We analyzed anti-spike and anti-nucleocapsid antibody responses following acute infection in a cohort of Indigenous persons. The models of peak concentrations and decay rates estimated that one year after infection, participants would serorevert for anti-nucleocapsid antibodies and remain seropositive for anti-spike antibodies. The peak anti-spike concentrations were higher for individuals vaccinated prior to infection, but the decay rates were similar across immunologic status groups. Children had significantly lower peak anti-spike concentrations than adults. This study affirms the importance of continued vaccination to maintain high levels of immunity in the face of waning immunity.
Open AccessThe Trajectory of Antibody Responses One Year Following SARS-CoV-2 Infection among Indigenous Individuals in the Southwest United States
SARS-CoV-2 antibody kinetics based on immunologic history is not fully understood. We analyzed anti-spike and anti-nucleocapsid antibody responses following acute infection in a cohort of Indigenous persons. The models of peak concentrations and decay rates estimated that one year after infection, participants would serorevert for anti-nucleocapsid antibodies and remain seropositive for anti-spike antibodies. The peak anti-spike concentrations were higher for individuals vaccinated prior to infection, but the decay rates were similar across immunologic status groups. Children had significantly lower peak anti-spike concentrations than adults. This study affirms the importance of continued vaccination to maintain high levels of immunity in the face of waning immunity.
- Open Access
- 17 April 2024
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 21 (4) , e1004387
Potential impact of annual vaccination with reformulated COVID-19 vaccines: Lessons from the US COVID-19 scenario modeling hub
Background: Coronavirus Disease 2019 (COVID-19) continues to cause significant hospitalizations and deaths in the United States. Its continued burden and the impact of annually reformulated vaccines remain unclear. Here, we present projections of COVID-19 hospitalizations and deaths in the United States for the next 2 years under 2 plausible assumptions about immune escape (20% per year and 50% per year) and 3 possible CDC recommendations for the use of annually reformulated vaccines (no recommendation, vaccination for those aged 65 years and over, vaccination for all eligible age groups based on FDA approval). Methods and findings: The COVID-19 Scenario Modeling Hub solicited projections of COVID-19 hospitalization and deaths between April 15, 2023 and April 15, 2025 under 6 scenarios representing the intersection of considered levels of immune escape and vaccination. Annually reformulated vaccines are assumed to be 65% effective against symptomatic infection with strains circulating on June 15 of each year and to become available on September 1. Age- and state-specific coverage in recommended groups was assumed to match that seen for the first (fall 2021) COVID-19 booster. State and national projections from 8 modeling teams were ensembled to produce projections for each scenario and expected reductions in disease outcomes due to vaccination over the projection period. From April 15, 2023 to April 15, 2025, COVID-19 is projected to cause annual epidemics peaking November to January. In the most pessimistic scenario (high immune escape, no vaccination recommendation), we project 2.1 million (90% projection interval (PI) [1,438,000, 4,270,000]) hospitalizations and 209,000 (90% PI [139,000, 461,000]) deaths, exceeding pre-pandemic mortality of influenza and pneumonia. In high immune escape scenarios, vaccination of those aged 65+ results in 230,000 (95% confidence interval (CI) [104,000, 355,000]) fewer hospitalizations and 33,000 (95% CI [12,000, 54,000]) fewer deaths, while vaccination of all eligible individuals results in 431,000 (95% CI: 264,000–598,000) fewer hospitalizations and 49,000 (95% CI [29,000, 69,000]) fewer deaths. Conclusions: COVID-19 is projected to be a significant public health threat over the coming 2 years. Broad vaccination has the potential to substantially reduce the burden of this disease, saving tens of thousands of lives each year.
- 17 April 2024
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 21 (4) , e1004387
Open AccessPotential impact of annual vaccination with reformulated COVID-19 vaccines: Lessons from the US COVID-19 scenario modeling hub
Background: Coronavirus Disease 2019 (COVID-19) continues to cause significant hospitalizations and deaths in the United States. Its continued burden and the impact of annually reformulated vaccines remain unclear. Here, we present projections of COVID-19 hospitalizations and deaths in the United States for the next 2 years under 2 plausible assumptions about immune escape (20% per year and 50% per year) and 3 possible CDC recommendations for the use of annually reformulated vaccines (no recommendation, vaccination for those aged 65 years and over, vaccination for all eligible age groups based on FDA approval). Methods and findings: The COVID-19 Scenario Modeling Hub solicited projections of COVID-19 hospitalization and deaths between April 15, 2023 and April 15, 2025 under 6 scenarios representing the intersection of considered levels of immune escape and vaccination. Annually reformulated vaccines are assumed to be 65% effective against symptomatic infection with strains circulating on June 15 of each year and to become available on September 1. Age- and state-specific coverage in recommended groups was assumed to match that seen for the first (fall 2021) COVID-19 booster. State and national projections from 8 modeling teams were ensembled to produce projections for each scenario and expected reductions in disease outcomes due to vaccination over the projection period. From April 15, 2023 to April 15, 2025, COVID-19 is projected to cause annual epidemics peaking November to January. In the most pessimistic scenario (high immune escape, no vaccination recommendation), we project 2.1 million (90% projection interval (PI) [1,438,000, 4,270,000]) hospitalizations and 209,000 (90% PI [139,000, 461,000]) deaths, exceeding pre-pandemic mortality of influenza and pneumonia. In high immune escape scenarios, vaccination of those aged 65+ results in 230,000 (95% confidence interval (CI) [104,000, 355,000]) fewer hospitalizations and 33,000 (95% CI [12,000, 54,000]) fewer deaths, while vaccination of all eligible individuals results in 431,000 (95% CI: 264,000–598,000) fewer hospitalizations and 49,000 (95% CI [29,000, 69,000]) fewer deaths. Conclusions: COVID-19 is projected to be a significant public health threat over the coming 2 years. Broad vaccination has the potential to substantially reduce the burden of this disease, saving tens of thousands of lives each year.